Hip
Senior Member
- Messages
- 17,873
The document @mission impossible is referring to is:
Myalgic Encephalomyelitis: Guidelines for Doctors
Journal of Chronic Fatigue Syndrome, Vol. 10(1) 2002, pp. 65-80
Author: John Richardson
Page 9 reads:
Myalgic Encephalomyelitis: Guidelines for Doctors
Journal of Chronic Fatigue Syndrome, Vol. 10(1) 2002, pp. 65-80
Author: John Richardson
Page 9 reads:
IgG Infusions have been used extensively both in the U.K. and abroad and the basis for this is considered to be the abnormal, cellular and humoral immunity in these patients. Replacement therapy with IgG is given to restore normal homoral immune function. Some clinicians use the I.V. infusions but we for many years have used I.M. injections. Professor R. Loria in personal communications has demonstrated the vortex of effects which occur when IgG is given I.M. rather than I.V. and thus it has more effective results. Also, instead of large amounts at extended intervals, we find that on average about 500 mg weekly has a "smoother" and more beneficial effect. However, before this therapy is given it is wise to do the serological tests alluded to earlier and show these to be positive.
The protective benefits may be seen by referring to the outcome in pregnancy. Over the years out of 249 female patients with high positive titers to a Coxsackie virus, 66 became pregnant. Forty-five of these (68.2%) had normal babies but the remaining 21 (31.8%) had abnormal babies. It is significant that for varying reasons, none of the mothers who had the abnormal babies had been protected by IgG infusions, but more than 90% of the remainder received IgG before and during pregnancy. (The records are retained.)